Bureaucracy Scuttles Release Of Antiviral Pills - The Daily Wire

Just more than two years since the first COVID-19 case was diagnosed in the U.S., scientists have created a powerful tool against the virus.

The antiviral COVID-19 pills “are less expensive and more practical than the single antibody treatment shown to be effective against the rapidly spreading Omicron variant, which has to be administered in a clinical setting.

The report comes after the CEO of the first company to win approval for a COVID-19 vaccine said he hopes the virus will be “controlled” by annual vaccinations and pills to treat illness when people get sick.

Albert Bourla, head of pharmaceutical giant Pfizer, said on CNBC that annual COVID-19 shots could become the norm, just like yearly flu shots.